Shengtai Pharmaceutical (SGTI) 10-Q 2010 Q2 Quarterly report

EXHIBIT 32.2

CERTIFICATION OF VICE PRESIDENT OF CORPORATE FINANCE

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, the Chief Financial Officer of Shengtai Pharmaceutical, Inc. (the "Company"), does hereby certify under the standards set forth and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 15, 2010	/s/ Yongqiang Wang
	Yongqiang Wang
	Title: Chief Financial Officer